These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7619167)

  • 1. Staging of head and neck cancer.
    Denic S
    N Engl J Med; 1995 Jun; 332(26):1789; author reply 1789-90. PubMed ID: 7619167
    [No Abstract]   [Full Text] [Related]  

  • 2. Staging of head and neck cancer.
    Kao GD; Rudoltz M
    N Engl J Med; 1995 Jun; 332(26):1788-9; author reply 1789-90. PubMed ID: 7760903
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
    van Houten VM; Tabor MP; van den Brekel MW; Kummer JA; Denkers F; Dijkstra J; Leemans R; van der Waal I; Snow GB; Brakenhoff RH
    J Pathol; 2002 Dec; 198(4):476-86. PubMed ID: 12434417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correspondence re: F. Coulet et al., Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis. Cancer Res., 60: 707-709, 2000.
    Silva JM; Bonilla F
    Cancer Res; 2001 Dec; 61(23):8595-6. PubMed ID: 11731447
    [No Abstract]   [Full Text] [Related]  

  • 5. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy.
    Ganly I; Soutar DS; Brown R; Kaye SB
    Br J Cancer; 2000 Jan; 82(2):392-8. PubMed ID: 10646894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
    van Houten VM; Leemans CR; Kummer JA; Dijkstra J; Kuik DJ; van den Brekel MW; Snow GB; Brakenhoff RH
    Clin Cancer Res; 2004 Jun; 10(11):3614-20. PubMed ID: 15173067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical applications of the diagnosis of p53 alterations in squamous cell carcinoma of the head and neck.
    Lopez-Martinez M; Anzola M; Cuevas N; Aguirre JM; De-Pancorbo M
    Med Oral; 2002; 7(2):108-20. PubMed ID: 11887018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53--master and commander.
    Foulkes WD
    N Engl J Med; 2007 Dec; 357(25):2539-41. PubMed ID: 18094374
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
    Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis.
    Coulet F; Blons H; Cabelguenne A; Lecomte T; Lacourreye O; Brasnu D; Beaune P; Zucman J; Laurent-Puig P
    Cancer Res; 2000 Feb; 60(3):707-11. PubMed ID: 10676657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical applications of DNA content parameters in patients with squamous cell carcinomas of the head and neck.
    Ensley JF; Maciorowski Z
    Semin Oncol; 1994 Jun; 21(3):330-9. PubMed ID: 8209264
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
    Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
    Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 mutations in head and neck cancer.
    Perrone F; Bossi P; Licitra L
    N Engl J Med; 2008 Mar; 358(11):1194-5; author reply 1195. PubMed ID: 18340660
    [No Abstract]   [Full Text] [Related]  

  • 15. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL; Sinha UK
    Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.
    González MV; Pello MF; López-Larrea C; Suárez C; Menéndez MJ; Coto E
    Clin Cancer Res; 1995 Sep; 1(9):1043-9. PubMed ID: 9816078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines.
    Bradford CR; Zhu S; Ogawa H; Ogawa T; Ubell M; Narayan A; Johnson G; Wolf GT; Fisher SG; Carey TE
    Head Neck; 2003 Aug; 25(8):654-61. PubMed ID: 12884349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.
    Haraf DJ; Nodzenski E; Brachman D; Mick R; Montag A; Graves D; Vokes EE; Weichselbaum RR
    Clin Cancer Res; 1996 Apr; 2(4):755-62. PubMed ID: 9816227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma.
    Ferris RL; Grandis JR
    Clin Cancer Res; 2007 Oct; 13(19):5663-4. PubMed ID: 17908953
    [No Abstract]   [Full Text] [Related]  

  • 20. No association between P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck.
    Hamel N; Black MJ; Ghadirian P; Foulkes WD
    Br J Cancer; 2000 Feb; 82(4):757-9. PubMed ID: 10732740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.